Glutamate: The Master Neurotransmitter and Its Implications in Chronic Stress and Mood Disorders

被引:69
作者
Pal, Mia Michaela [1 ]
机构
[1] In Cognit UK, Church Lawton, England
来源
FRONTIERS IN HUMAN NEUROSCIENCE | 2021年 / 15卷
关键词
glutamate; neuroplasticity; GABA; NMDA-receptor; long-term potentiation; MAGNETIC-RESONANCE-SPECTROSCOPY; LONG-TERM POTENTIATION; PARTIAL AGONIST; KETAMINE; DEPRESSION; METAANALYSIS; INHIBITION; MODULATION; MECHANISMS; GLYX-13;
D O I
10.3389/fnhum.2021.722323
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This brief review article makes the argument that glutamate is deserving of its newfound attention within the neuroscience literature and that many directions of important research have yet to be explored. Glutamate is an excitatory neurotransmitter with several types of receptors found throughout the central nervous system, and its metabolism is important to maintaining optimal levels within the extracellular space. As such, it is important to memory, cognition, and mood regulation. The mechanisms by which chronic stress affect the glutamatergic system and neuroplasticity are outlined. Several implications for potential pharmacologic and non-pharmacologic interventions are discussed.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Impact of Inflammation-induced Glutamate Increases on Neuroprogression Among Patients with Mood Disorders
    Haroon, Ebrahim
    Miller, Andrew H.
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 310S - 310S
  • [22] Editorial: The glutamate hypothesis of mood disorders: Neuroplasticity processes, clinical features, treatment perspectives
    Guglielmo, Riccardo
    de Filippis, Rocco
    Ouanes, Sami
    Hasler, Gregor
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [23] Common aspects of neuroplasticity, stress, mood disorders and mitochondrial functions
    Fisar, Zdenek
    Hroudova, Jana
    ACTIVITAS NERVOSA SUPERIOR REDIVIVA, 2010, 52 (01):
  • [24] Increased levels of glutamate in brains from patients with mood disorders
    Hashimoto, Kenji
    Sawa, Akira
    Iyo, Masaomi
    BIOLOGICAL PSYCHIATRY, 2007, 62 (11) : 1310 - 1316
  • [25] Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: Focus on pharmacology and preclinical translational models
    Harvey, Brian H.
    Shahid, Mohammed
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2012, 100 (04) : 775 - 800
  • [26] The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects
    Maeng S.
    Zarate Jr. C.A.
    Current Psychiatry Reports, 2007, 9 (6) : 467 - 474
  • [27] The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders
    Millan, Mark J.
    Rivet, Jean-Michel
    Gobert, Alain
    JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (11) : 1099 - 1128
  • [28] Self-Compassion Across Anxiety and Mood Disorders: Implications for Treatment
    Bommarito, Sarah
    Stevenson, Alyssa
    Warren, Ricks
    CURRENT PSYCHIATRY REPORTS, 2025, 27 (02) : 134 - 139
  • [29] Adverse childhood experiences associate to reduced glutamate levels in the hippocampus of patients affected by mood disorders
    Poletti, Sara
    Locatelli, Clara
    Falini, Andrea
    Colombo, Cristina
    Benedetti, Francesco
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 71 : 117 - 122
  • [30] Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics
    Newell, Kelly A.
    Matosin, Natalie
    BMC PSYCHIATRY, 2014, 14